Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Michael E. Kafrissen"'
Publikováno v:
Obstetrics & Gynecology. 96:913-920
Objective: To compare the efficacy of a triphasic combination oral contraceptive (OC) containing norgestimate and ethinyl estradiol (E2) and placebo in the treatment of metrorrhagic, menometrorrhagic, oligomenorrheic, and polymenorrheic dysfunctional
Autor:
Michael E. Kafrissen, Jean Davignon, Alcide Chapdelaine, A. Christine Nestruck, Hubert Arslanian, Suzanne Lussier-Cacan, Marianne Xhignesse
Publikováno v:
Fertility and Sterility. 53:28-34
The influence of a triphasic oral contraceptive preparation on plasma lipid, lipoprotein, and apolipoprotein levels was studied in 20 women during 12 treatment cycles. Multiple blood samples representing all phases of the therapeutic cycle as well as
Autor:
David F. Archer, Edmond A. Dowling, Frederick Cone, George W. Creasy, Michael E. Kafrissen, Kathleen McIntyre-Seltman, Walter W. Wilborn
Publikováno v:
American journal of obstetrics and gynecology. 165(2)
Few data are available regarding endometrial histologic features in asymptomatic perimenopausal and postmenopausal women. This study encompasses endometrial biopsy specimens obtained from 801 such women before enrollment in a multicenter study of est
Autor:
Alcide Chapdelaine, Marianne Xhignesse, Jean-Luc Desmarais, Jean Davignon, Suzanne Lussier-Cacan, Michael E. Kafrissen
Publikováno v:
Metabolism: clinical and experimental. 40(8)
The influence of menstrual cycle phases and hormonal contraception on serum lipid and apolipoprotein (apo) levels was investigated in a group of normally menstruating young women. The study period covered a normal menstrual cycle (pretherapy), the fo
Autor:
Michael E. Kafrissen
Publikováno v:
International Journal of Gynecology & Obstetrics. 41:335-335
Despite the well-documented efficacy and safety of low-dose oral contraceptives, the development of newer formulations containing highly selective progestins with minimal or no androgenic activity has been a goal of pharmaceutical research. The effic
Publikováno v:
Obstetrical & Gynecological Survey. 47:654
Several controversial areas have been reviewed. It would seem from the evidence at hand that progression from endometrial hyperplasia to endometrial carcinoma does occur in a significant percentage of women and that endometrial hyperplasia, particula
Publikováno v:
Obstetrics & Gynecology. 68:387-389
This report describes a cluster of four abortion-related deaths at a single facility from 1979 to 1983. The deaths followed curettage abortions at eight to 18 weeks' gestation. One death was attributed to a prolapsed mitral valve, and one was attribu
Publikováno v:
JAMA. 251(7)
Although dilatation and evacuation (D&E) is currently the most common method of midtrimester abortion in the United States, the intra-amniotic instillation of hyperosmolar urea and prostaglandin F2 alpha combined (U-P) has been proposed as a safer te
Publikováno v:
American journal of obstetrics and gynecology. 147(3)
The relative risks of coagulopathy from suction curettage, dilatation and evacuation (D and E), and saline instillation were examined using the records of all women obtaining abortions at the Inglewood Hospital in California from February 1980-Septem
Autor:
Michael E. Kafrissen
Publikováno v:
JAMA. 251:916